TP53 and gonorrhea: The study of TP53_2 polymorphism (locus rs17884159) showed that in patients with invasive PAs, the frequency of the heterozygous variant (C/T) was significantly higher — 15.4% (n=8) compared to the control group — 4.8% (n=4).